Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

8167 items · filings · clear filters

  • SEC EDGAR•filings
    8-K - OMNIQ Corp. (0000278165) (Filer)

    Automated noteOMNIQ Corp filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - Summit Therapeutics Inc. (0001599298) (Filer)

    Automated noteSummit Therapeutics Inc. filed a Form 8-K on September 15, 2026, reporting other events under Item 8.01 and providing financial statements and exhibits under Item 9.01.

  • SEC EDGAR•filings
    8-K - SCOTTS MIRACLE-GRO CO (0000825542) (Filer)

    Automated noteScotts Miracle-Gro Co. filed a Form 8-K on September 15, 2026 reporting the termination of a material definitive agreement, disclosing other events, and providing accompanying financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - BIOMARIN PHARMACEUTICAL INC (0001048477) (Filer)

    Automated noteBiomarin Pharmaceutical Inc. filed a Form 8-K with the SEC on September 15, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001628280-26-061973).

  • SEC EDGAR•filings
    8-K - Scholar Rock Holding Corp (0001727196) (Filer)

    Automated noteScholar Rock Holding Corp filed a Form 8-K with the SEC on September 15, 2026, providing a Regulation FD disclosure under Item 7.01.

  • SEC EDGAR•filings
    8-K - Evommune, Inc. (0002044725) (Filer)

    Automated noteEvommune, Inc. filed a Form 8-K with the SEC on September 15, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - USA TODAY Co., Inc. (0001579684) (Filer)

    Automated noteUSA TODAY Co., Inc. filed a Form 8-K on September 15, 2026 reporting departures, appointments, and compensation arrangements for certain officers, along with a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - AGNT, Inc. (0001495932) (Filer)

    Automated noteAGNT, Inc. filed a Form 8-K with the SEC on September 15, 2026, reporting under Item 8.01 (Other Events). The filing, accession number 0001104659-26-107720, is 156 KB in size.

  • SEC EDGAR•filings
    8-K - AETHLON MEDICAL INC (0000882291) (Filer)

    Automated noteAethlon Medical Inc. filed a Form 8-K on September 15, 2026 reporting the departure and appointment of certain officers, related compensatory arrangements, and providing its financial statements and accompanying exhibits.

  • SEC EDGAR•filings
    8-K - Otis Worldwide Corp (0001781335) (Filer)

    Automated noteOtis Worldwide Corp filed a Form 8-K on September 15, 2026, disclosing departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Coya Therapeutics, Inc. (0001835022) (Filer)

    Automated noteCoya Therapeutics, Inc. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on September 15, 2026 (Accession No. 0001193125-26-391378).

  • SEC EDGAR•filings
    8-K - INTRUSION INC (0000736012) (Filer)

    Automated noteIntrusion Inc filed a Form 8-K on September 15, 2026 reporting the departure, election, or appointment of certain directors or officers and related compensatory arrangements.

  • SEC EDGAR•filings
    8-K - Vera Bradley, Inc. (0001495320) (Filer)

    Automated noteVera Bradley, Inc. filed a Form 8-K on September 15, 2026, including Item 2.02 reporting its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - EIDP, Inc. (0000030554) (Filer)

    Automated noteEIDP, Inc. filed a Form 8-K with the SEC on September 15, 2026 (Accession No. 0001193125-26-391369), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Corteva, Inc. (0001755672) (Filer)

    Automated noteCorteva, Inc. submitted a Form 8-K on September 15, 2026 (Accession No. 0001193125-26-391369) containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - RB GLOBAL INC. (0001046102) (Filer)

    Automated noteRB Global Inc. filed a Form 8-K on September 15, 2026, reporting other events and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - LB PHARMACEUTICALS INC (0001691082) (Filer)

    Automated noteLB Pharmaceuticals filed a Form 8-K on September 15, 2026, reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - NextTrip, Inc. (0000788611) (Filer)

    Automated noteNextTrip, Inc. filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Sadot Group Inc. (0001701756) (Filer)

    Automated noteSadot Group Inc. filed a Form 8-K reporting a material definitive agreement, changes to directors and officers with related compensation arrangements, amendments to its articles and bylaws, a shareholder vote, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - CHEETAH NET SUPPLY CHAIN SERVICE INC. (0001951667) (Filer)

    Automated noteCheetah Net Supply Chain Service Inc. filed a Form 8-K on September 15, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ASPEN AEROGELS INC (0001145986) (Filer)

    Automated noteAspen Aerogels Inc. filed a Form 8-K on September 15, 2026, reporting a Regulation FD disclosure and providing its financial statements and related exhibits as required under Items 7.01 and 9.01.

  • SEC EDGAR•filings
    8-K - Quality Industrial Corp. (0001393781) (Filer)

    Automated noteQuality Industrial Corp. filed a Form 8-K on September 15, 2026, reporting amendments to its articles of incorporation or bylaws and a change in its fiscal year, and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Cushman & Wakefield Ltd. (0001628369) (Filer)

    Automated noteCushman & Wakefield Ltd. filed a Form 8-K on September 15, 2026, disclosing departures, elections, appointments and compensatory arrangements for certain officers, and included its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - LINDBLAD EXPEDITIONS HOLDINGS, INC. (0001512499) (Filer)

    Automated noteLindblad Expeditions Holdings filed a Form 8-K on September 15, 2026, reporting entry into a material definitive agreement, providing a Regulation FD disclosure, and including financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - QUANTUM X LABS INC. (0000797542) (Filer)

    Automated noteQuantum X Labs Inc. submitted a Form 8-K on September 15, 2026 (Accession No. 0001493152-26-042665), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Zeo ScientifiX, Inc. (0001557376) (Filer)

    Automated noteZeo ScientifiX, Inc. filed a Form 8-K on September 15, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - AMERICAN EXPRESS CO (0000004962) (Filer)

    Automated noteAmerican Express filed a Form 8-K with the SEC on September 15, 2026, under Item 7.01, providing a Regulation FD disclosure.

  • SEC EDGAR•filings
    8-K - BlossomHill Therapeutics, Inc. (0001839970) (Filer)

    Automated noteBlossomHill Therapeutics, Inc. filed a Form 8-K on September 15, 2026, which includes a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - AXON ENTERPRISE, INC. (0001069183) (Filer)

    Automated noteAxon Enterprise filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance sheet arrangement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Driven Brands Holdings Inc. (0001804745) (Filer)

    Automated noteDriven Brands Holdings Inc. filed a Form 8-K on September 15, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.